US National Institutes of Health (NIH) offers Creutzfeldt Jakob Disease (CJD) test licence:
This article was originally published in Clinica
Executive Summary
The US National Institutes of Health is offering a non-exclusive licence to the 14-3-3 protein test for spongiform encephalopathies, which was published by the New England Journal of Medicine in September (see Clinica No 725, p 15). Enquiries concerning the NIH licence should be addressed to Dr George Keller, Office of Technology Transfer. Tel: +1 301 496 7735 ext 246. Fax: +1 301 402 0220.